Hematoma, Subdural clinical trials

The registry lists 44 studies for Hematoma, Subdural across more than 10 countries. 15 are recruiting or about to start. 14 of them are mainly about Hematoma, Subdural (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its narrower condition Hematoma, Subdural, Chronic too: 147 studies, 58 open.

Get an email when these change. Save the Hematoma, Subdural studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 18
Recruiting: 10
Not yet recruiting: 5
Withdrawn: 3
Status unknown: 3
Terminated: 3

Phase

Phase 4: 3
Phase 2: 3
Phase 3: 2
Phase 1: 2

Where

United States: 21
Canada: 5
China: 2
Japan: 2
United Kingdom: 2
Italy: 2

Who runs them

Children's Hospital Medical Center, Cincinnati (7) · Assiut University (2) · Sunnybrook Health Sciences Centre (2) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Massachusetts General Hospital (1) · Sohag University (1) · Nottingham University Hospitals NHS Trust (1) · Ohio State University (1)

What is being tested here

Drugs under test in Hematoma, Subdural studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Cisatracurium	1	0	1
Temozolomide	0	0	1
Tissue Plasminogen Activator	0	0	1
Apixaban	0	1	1
Rivaroxaban	0	1	1
Edoxaban	0	1	1
Dabigatran	0	1	1
Acenocoumarol	0	1	1
Warfarin	0	1	1
Tranexamic Acid	0	0	1

Coming up

1phase 3 study under way

5studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5, phase 3 first

Mar 2027The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma · Phase 3 · Unity Health Toronto
Dec 2026Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) · Aesculap AG
Feb 2027Non-Thermal Plasma to Reduce Recurrence in Chronic Subdural Hematoma · Benjamín Gonzalo Rodríguez Méndez
Jun 2027Neurosurgical Outcome Network · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Oct 2027Outcomes of Traumatic Intracranial Hemorrhage in the Elderly · Assiut University

Who these studies take

Of the 10 Hematoma, Subdural studies recruiting now, 7 (70%) set no upper age limit and 1 (10%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	0 (0%)	0 (0%)
18	9 (90%)	9 (90%)
30	9 (90%)	9 (90%)
40	9 (90%)	9 (90%)
50	10 (100%)	10 (100%)
65	10 (100%)	10 (100%)
75	10 (100%)	10 (100%)
85	9 (90%)	9 (90%)

Across all 44 studies, recruiting or not: 27% stop at 75 or younger and 25% at 65; 23% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 44 of 44. search them.